Altimmune Inc logo

Altimmune Inc

1
1
NAS:ALT (USA)  
$ 13.28 -0.53 (-3.84%) 04:00 PM EST
At Loss
P/B:
4.85
Market Cap:
$ 742.00M
Enterprise V:
$ 602.00M
Volume:
11.41M
Avg Vol (2M):
6.83M
Also Trade In:
Volume:
11.41M
At Loss
Avg Vol (2M):
6.83M

Business Description

Description
Altimmune Inc is engaged on developing treatments for obesity and liver diseases. The Company's pipeline includes next generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.
Name Current Vs Industry Vs History
Cash-To-Debt 178.65
Equity-to-Asset 0.9
Debt-to-Equity 0.01
Debt-to-EBITDA -0.01
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 23.33
Distress
Grey
Safe
Beneish M-Score 5.21
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 90.21
9-Day RSI 79.16
14-Day RSI 71.58
6-1 Month Momentum % 288.75
12-1 Month Momentum % -21.13

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 12.89
Quick Ratio 12.89
Cash Ratio 11.86
Days Sales Outstanding 541.61

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -47.6
Shareholder Yield % -1.84

Financials (Next Earnings Date:2024-02-28 Est.)

ALT's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ALT

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Altimmune Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.279
EPS (TTM) ($) -1.54
Beta -0.45
Volatility % 278.28
14-Day RSI 71.58
14-Day ATR ($) 1.119794
20-Day SMA ($) 9.6655
12-1 Month Momentum % -21.13
52-Week Range ($) 2.09 - 14.5
Shares Outstanding (Mil) 53.73

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Altimmune Inc Filings

Filing Date Document Date Form
No Filing Data

Altimmune Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Altimmune Inc Frequently Asked Questions

What is Altimmune Inc(ALT)'s stock price today?
The current price of ALT is $13.28. The 52 week high of ALT is $14.50 and 52 week low is $2.09.
When is next earnings date of Altimmune Inc(ALT)?
The next earnings date of Altimmune Inc(ALT) is 2024-02-28 Est..
Does Altimmune Inc(ALT) pay dividends? If so, how much?
Altimmune Inc(ALT) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1